Circulating tumour cells in breast cancer

Lancet Oncology

Volumn 5, Issue 2, 2004, Pages 79-88

  Ring, Alistair ^a   Smith, Ian E ^a   Dowsett, Mitch ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKERATIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; RNA;

BLOOD ANALYSIS; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER RESEARCH; CELL SELECTION; CELL TRANSPORT; CONTROLLED STUDY; CYTOMETRY; DNA SEQUENCE; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MATERIALS HANDLING; MEDICAL DECISION MAKING; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; TUMOR CELL; TUMOR LOCALIZATION;

BREAST NEOPLASMS; DNA, NEOPLASM; HUMANS; NEOPLASM CIRCULATING CELLS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 0742323734     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01381-6     Document Type: Review

References (75)

1. Simpson SJ Vachula M Kennedy MJ et al. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry Exp Hematol 23 1995 1062-1068
2. Franklin WA Shpall EJ Archer P et al. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support Breast Cancer Res Treat 41 1996 1-13
3. Sloane JP Ormerod MG Imrie SF Coombes RC. The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections Br J Cancer 42 1980 392-398
4. Martin VM Siewert C Scharl A et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS Exp Hematol 26 1998 252-264
5. Pachmann K Heiss P Demel U Tilz G. Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC) Clin Chem Lab Med 39 2001 811-817
6. Naume B Borgen E Beiske K et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood J Hematother 6 1997 103-114
7. Racila E Euhus D Weiss AJ et al. Detection and characterization of carcinoma cells in the blood Proc Natl Acad Sci USA 95 1998 4589-4594
8. Gross HJ Verwer B Houck D et al. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7) Proc Natl Acad Sci USA 92 1995 537-541
9. Moll R. Cytokeratins in the histological diagnosis of malignant tumors Int J Biol Markers 9 1994 63-69
10. Fehm T Sagalowsky A Clifford E et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant Clin Cancer Res 8 2002 2073-2084
11. Leon SA Shapiro B Sklaroff DM Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 37 1977 646-650
12. Silva JM Dominguez G Villaneuva MJ et al. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients Br J Cancer 80 1999 1262-1264
13. Taback B Giuliano AE Hansen NM Hoon DS. Microsatellite alterations detected in the serum of early stage breast cancer patients Ann N Y Acad Sci 945 2001 22-30
14. West DC Grier HE Swallow MM et al. Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor J Clin Oncol 15 1997 583-588
15. Kobayashi Y Yoshinouchi M Tianqi G et al. Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes Clin Cancer Res 4 1998 979-983
16. Tada M Omata M Kawai S et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Res 53 1993 2472-2544
17. Ng EKO Tsui NBY Lau TK et al. mRNA of placental origin is readily detectable in maternal plasma Proc Natl Acad Sci USA 100 2003 4748-4753
18. de Cremoux P Extra JM Denis MG et al. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction Clin Cancer Res 6 2000 3117-3122
19. Aerts J Wynendaele W Paridaens R et al. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood Ann Oncol 12 2001 39-46
20. Palomares MR, Richardson-Lander A, Koehler KM, et al. Quantitative real-time RT-PCR for the detection of circulating breast cancer cells: correlation with stage and treatment. In: Proceedings of 26th Annual San Antonio Breast Cancer Symposium, 2002; abstr 217.
21. Slade MJ Smith BM Sinnett HD et al. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer J Clin Oncol 17 1999 870-879
22. Smith BM Slade MJ English J et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques J Clin Oncol 18 2000 1432-1439
23. Lambrechts AC Bosma AJ Klaver SG et al. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells Breast Cancer Res Treat 56 1999 219-231
24. Wingren S Guerrieri C Franlund B Stal O. Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure Anal Cell Pathol 9 1995 229-233
25. Gradilone A Gazzaniga P Silvestri I et al. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease Oncol Rep 10 2003 217-222
26. Grunewald K Haun M Urbanek M et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19 Lab Invest 80 2000 1071-1077
27. Silva JM Dominguez G Silva J et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics Clin Cancer Res 7 2001 2821-2825
28. Bosma AJ Weigelt B Lambrechts AC et al. Detection of circulating breast tumor cells by differential expression of marker genes Clin Cancer Res 8 2002 1871-1877
29. Taback B Chan AD Kuo CT et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease Cancer Res 61 2001 8845-8850
30. Jung R Petersen K Kruger W et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes Br J Cancer 81 1999 870-873
31. Burchill SA Bradbury MF Pittman K et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction Br J Cancer 71 1995 278-281
32. Eltahir EM Mallinson DS Birnie GD Purushotham AD et al. Putative markers for the detection of breast carcinoma cells in blood Br J Cancer 77 1998 1203-1207
33. Bostick PJ Chatterjee S Chi DD et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients J Clin Oncol 16 1998 2632-2640
34. Zippelius A Kufer P Honold G et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow J Clin Oncol 15 1997 2701-2708
35. Pantel K Schlimok G Angstwurm M et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow J Hematother 3 1994 165-173
36. Braun S Muller M Hepp F et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status J Natl Cancer Inst 90 1998 1099-1101
37. de Graaf H Maelandsmo GM Ruud P et al. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2 Int J Cancer 72 1997 191-196
38. Brandt B Roetger A Heidl S et al. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients Int J Cancer 76 1998 824-828
39. Witzig TE Bossy B Kimlinger T et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy Clin Cancer Res 8 2002 1085-1091
40. Schoenfeld A Kruger KH Gomm J et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19 Eur J Cancer 33 1997 854-861
41. Kim SJ Ikeda N Shiba E et al. Detection of breast cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry Breast Cancer 8 2001 63-69
42. Bischoff J, Gutschow K, Rosenberg R, et al. Detection of disseminated tumor cells in the bone marrow and peripheral blood of patients with metastatic breast cancer. In: Proceedings of the American Society of Clinical Oncology, 2002 abstr 1994.
43. Kruger W Krzizanowski C Holweg M et al. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients J Cancer Res Clin Oncol 122 1996 679-686
44. Krag DN Ashikaga T Moss TJ et al. Breast cancer cells in the blood: a pilot study Breast J 5 1999 354-358
45. Stathopoulou A Vlachonikolis I Mavroudis D et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol 20 2002 3404-3412
46. Silva AL Tome MJ Correia AE Passos-Coelho JL. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products Ann Oncol 13 2002 422-429
47. Kahn HJ Yang LY Blondal J et al. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters Breast Cancer Res Treat 60 2000 143-151
48. Zach O Kasparu H Krieger O et al. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA J Clin Oncol 17 1999 2015-2019
49. Hoon DS Sarantou T Doi F et al. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction Int J Cancer 69 1996 369-374
50. Sabbatini R Federico M Morselli M et al. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy J Clin Oncol 18 2000 1914-1920
51. Bossolasco P Ricci C Farina G et al. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene Cancer Detect Prev 26 2002 60-63
52. Leitzel K Lieu B Curley E et al. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor Clin Cancer Res 4 1998 3037-3043
53. Datta YH Adams PT Drobyski WR et al. Sensitive detection of occult breast cancer by the reverse- transcriptase polymerase chain reaction J Clin Oncol 12 1994 475-482
54. De Luca A Pignata S Casamassimi A et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay Clin Cancer Res 6 2000 1439-1444
55. Stathopoulou A Angelopoulou K Perraki M et al. Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer Clin Biochem 34 2001 651-659
56. Berois N Varangot M Aizen B et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer: comparison of CK19, MUC1 and CEA using RT-PCR Eur J Cancer 36 2000 717-723
57. Manhani AR Manhani R Soares HP et al. CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy Breast Cancer Res Treat 66 2001 249-254
58. Fonseca FL Soares HP Manhani AR et al. Peripheral blood c-erbB-2 expression by reverse-transcriptase-polymerase chain reaction in breast cancer patients receiving chemotherapy Clin Breast Cancer 3 2002 201-205
59. Soria JC Gauthier LR Raymond E et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients Clin Cancer Res 5 1999 971-975
60. Jung R Kruger W Hosch S et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro Br J Cancer 78 1998 1194-1198
61. Goeminne JC Guillaume T Salmon M et al. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors Bone Marrow Transplant 24 1999 769-775
62. Kaplan JC Kahn A Chelly J. Illegitimate transcription: its use in the study of inherited disease Hum Mutat 1 1992 357-360
63. Ruud P Fodstad O Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells Int J Cancer 80 1999 119-125
64. Weigelt B Bosma AJ Hart AA et al. Marker genes for circulating tumour cells predict survival in metastasized breast cancer pateints Br J Cancer 88 2003 1091-1094
65. Ladanyi A Soong R Tabiti K et al. Quantitative reverse transcription-PCR comparison of tumor cell enrichment methods Clin Chem 47 2001 1860-1863
66. The European ISHAGE Working Group for the Standardisation of Tumour Cell Detection Standardization of the immunocytochemical detection of cancer cells in BM and blood: I establishment of objective criteria for the evaulation of immunostained cells Cytotherapy 1 1999 377-388
67. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51 (18 suppl) : 5054s-59s.
68. Choy A McCulloch P. Induction of tumour cell shedding into effluent venous blood breast cancer surgery Br J Cancer 73 1996 79-82
69. Mehes G Witt A Kubista E Ambros PF. Circulating breast cancer cells are frequently apoptotic Am J Pathol 159 2001 17-20
70. Pantel K von Knebel Doeberitz M. Detection and clinical relevance of micrometastatic cancer cells Curr Opin Oncol 12 2000 95-101
71. Funke I Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated J Clin Oncol 16 1998 557-566
72. Zach O Kasparu H Wagner H et al. Prognostic value of tumour cell detection in peripheral blood of breast cancer patients Acta Med Austriaca 29 suppl 59 2002 32-34
73. Schlimok G Pantel K Loibner H et al. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours Eur J Cancer 31A 1995 1799-1803
74. Pantel K Schlimok G Braun S et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells J Natl Cancer Inst 85 1993 1419-1424
75. Pachmann KM. The Maintrac analysis of circulating tumor cells allows the direct monitoring of the effect of adjuvant chemotherapy in breast cancer patients. Proc Am Soc Clin Oncol 2001; abstr 1786.